Odyssey Health, Inc. (ODYY)
OTCMKTS · Delayed Price · Currency is USD
0.0099
-0.0001 (-1.00%)
Aug 20, 2026, 3:25 PM EST
Odyssey Health Balance Sheet
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Equivalents | 0.3 | 0.02 | 0 | 0.04 | 0.07 | 0.56 |
Cash & Short-Term Investments | 0.3 | 0.02 | 0 | 0.04 | 0.07 | 0.56 |
Cash Growth | 9247.33% | 702.19% | -93.55% | -49.18% | -86.97% | 784.14% |
Other Receivables | - | - | 0.02 | 0.28 | 0.37 | - |
Receivables | - | - | 0.02 | 0.28 | 0.37 | - |
Prepaid Expenses | 0.08 | 0.03 | 0.03 | 0.09 | 0.09 | 0.05 |
Total Current Assets | 0.37 | 0.05 | 0.06 | 0.41 | 0.53 | 0.61 |
Property, Plant & Equipment | - | - | - | - | - | 0 |
Long-Term Investments | - | - | 0.53 | - | - | - |
Other Intangible Assets | - | - | - | 0.05 | 0.04 | - |
Total Assets | 0.37 | 0.05 | 0.59 | 0.46 | 0.57 | 0.61 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Accounts Payable | 1.48 | 1.62 | 1.4 | 1.8 | 1.55 | 1.22 |
Accrued Expenses | 2.44 | 2.28 | 1.75 | 1.54 | 1.01 | 0.29 |
Short-Term Debt | 2.64 | 1.98 | 1.65 | 2.14 | 1.53 | 0.74 |
Other Current Liabilities | 3.56 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
Total Current Liabilities | 10.12 | 7 | 5.92 | 6.61 | 5.21 | 3.38 |
Total Liabilities | 10.12 | 7 | 5.92 | 6.61 | 5.21 | 3.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.08 | 0.08 | 0.09 |
Additional Paid-In Capital | 56.21 | 55.69 | 55.57 | 53.86 | 49.46 | 42.88 |
Retained Earnings | -66.07 | -62.75 | -61 | -60.1 | -54.18 | -45.73 |
Shareholders' Equity | -9.75 | -6.95 | -5.33 | -6.16 | -4.64 | -2.77 |
Total Liabilities & Equity | 0.37 | 0.05 | 0.59 | 0.46 | 0.57 | 0.61 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Total Debt | 2.64 | 1.98 | 1.65 | 2.14 | 1.53 | 0.74 |
Net Cash (Debt) | -2.34 | -1.97 | -1.64 | -2.11 | -1.46 | -0.18 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 | -0.00 |
Filing Date Shares Outstanding | 100.97 | 99.85 | 96.71 | 81.73 | 71.99 | 91.02 |
Total Common Shares Outstanding | 100.97 | 96.71 | 96.71 | 79.07 | 77.86 | 87.19 |
Working Capital | -9.75 | -6.95 | -5.86 | -6.21 | -4.69 | -2.77 |
Book Value Per Share | -0.10 | -0.07 | -0.06 | -0.08 | -0.06 | -0.03 |
Tangible Book Value | -9.75 | -6.95 | -5.33 | -6.21 | -4.69 | -2.77 |
Tangible Book Value Per Share | -0.10 | -0.07 | -0.06 | -0.08 | -0.06 | -0.03 |